Login
Login     |     Register     |     Recover Username/Password

Technology Stocks

On-demand Software

August 06, 2007

Here at TWST, we also provide on-demand software for event registration.  We serve most of the investment banks who do not (wisely) choose to build their won – and a lot of the Companies Analyst Days too.    So we can echo every word here spoken by Bradley Mook Technology Analyst at Boenning & Scattergood.

TWST: Are there barriers to entry here or is it a free for all?

Mr. Mook: It’s still a bit of a free for all. Certainly expertise is necessary in the application area. You have to know what you’re designing the application for and be able to code it, and there are intricacies involved with hosting and maintaining the software. It is a lower-cost entry, though, so that does make it easier for competitors to enter the market. That and low customer switching costs actually keep the software companies on their toes. It means they need to continue to innovate and provide good service.

TWST: It sounds like a successful model. What’s the risk in the space?

Mr. Mook: At the end of the day, the software needs to do what it says it is going to do, because with low switching costs for customers, the software vendor is more easily held accountable. Also, as a software buyer .. there’s complexities for buyers. Do I choose the small best-of-breed provider that has a great application or do I go with the more established vendor that has a broader vision, but may not be the best in the individual application areas? You don’t just go out and buy Oracle (ORCL) – now you’ve got to figure out how to invest in this space.

This is from our Computer Software Report this week.


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now